SCHEMBL10559142

SCHEMBL10559142

COc1cc(S(C)(=O)=O)ccc1-c1nc2cc3c(cc2[nH]1)N(C(C)=O)CC3(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.41
CCNA2 P20248 1/20 0.41
CCND1 P24385 1/20 0.41
CDK2 P24941 1/20 0.41
CCND3 P30281 1/20 0.41
GCK P35557 2/20 0.37
SCD O00767 6/20 0.36
NPBWR1 P48145 1/20 0.36
PDE5A O76074 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
NOTUM Q6P988 1/20 0.35
AMY1A P0DUB6 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CBFB Q13951 1/20 0.34
FADS1 O60427 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10642049 0.85 NPC1 (0.36) GCKPDE5APDE3BPDE3ANOTUM
Hydrochloric Acid SCHEMBL10698205 0.75 AURKA (0.52) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10558554 0.75 NOTUM (0.49) SCDNPBWR1NOTUMGAAMAPT
SCHEMBL10373442 0.75 PDE3B (0.48) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9703598 0.75 CDK4 (0.41) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9383861 0.75 CDK4 (0.41) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10763240 0.74 CDK4 (0.45) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL10559157 0.73 NOTUM (0.37) NOTUMLMNASMN1; SMN2
SCHEMBL9703335 0.73 CDK4 (0.47) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9704446 0.72 CDK4 (0.42) CDK4CCNA2CCND1CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863945-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
EP-0271040-A2 Pyrrolobenzimidazoles, process for their preparation, and medicaments Roche Diagnostics GmbH (DE) 1988-06-15 EP disclosed